Viewing Study NCT00517920


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:20 AM
Study NCT ID: NCT00517920
Status: COMPLETED
Last Update Posted: 2013-01-04
First Post: 2007-08-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module